0001818382-22-000161.txt : 20220919
0001818382-22-000161.hdr.sgml : 20220919
20220919163628
ACCESSION NUMBER: 0001818382-22-000161
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220915
FILED AS OF DATE: 20220919
DATE AS OF CHANGE: 20220919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Niklason Laura E
CENTRAL INDEX KEY: 0001878075
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39532
FILM NUMBER: 221250979
MAIL ADDRESS:
STREET 1: 35 WILSHIRE ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06831
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Humacyte, Inc.
CENTRAL INDEX KEY: 0001818382
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851763759
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919-313-9633
MAIL ADDRESS:
STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54
CITY: DURHAM
STATE: NC
ZIP: 27713
FORMER COMPANY:
FORMER CONFORMED NAME: Alpha Healthcare Acquisition Corp.
DATE OF NAME CHANGE: 20200716
4
1
wf-form4_166361976999359.xml
FORM 4
X0306
4
2022-09-15
0
0001818382
Humacyte, Inc.
HUMA
0001878075
Niklason Laura E
2525 EAST NORTH CAROLINA HIGHWAY 54
DURHAM
NC
27713
1
1
1
0
President, CEO and Director
Common Stock
2022-09-15
4
S
0
1522500
4
D
18930004
I
By Ayabudge LLC
Common Stock
1158240
D
Common Stock
510161
I
By spouse
This sale was made by an entity controlled by the spouse of Laura Niklason, the Reporting Person. This sale was done as a block trade to an existing investor of Humacyte, Inc. Laura Niklason is treated as indirectly beneficially owning the shares sold, resulting in the requirement to file this Form 4. However, no shares directly owned by Laura Niklason were sold in this transaction.
/s/ Laura E. Niklason by Dale A. Sander as Attorney-in-Fact
2022-09-19